Cognitive Behavioral Therapy for Insomnia: Mechanisms, Efficacy, and an Evidence-Based Framework for Guided Self-Implementation

Abstract

Background: Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia disorder, yet access to trained clinicians remains limited. Self-help and digital formats have expanded reach, but their use is often guided by simplified or inaccurate descriptions of the underlying techniques.

Objective: This narrative review (a) integrates theoretical and empirical accounts of how CBT-I works, (b) summarizes evidence for its components and delivery formats, and (c) translates this evidence into a structured, safety-conscious framework for self-implementation.

Main findings: CBT-I targets perpetuating factors of insomnia: conditioned arousal, compensatory time-in-bed extension, sleep-related cognitive arousal, and dysfunctional beliefs. Meta-analytic evidence supports large benefits for insomnia severity, with durable effects and benefits for comorbid conditions. Self-help and digital formats show small-to-moderate and moderate effects respectively, generally smaller and less consistent than therapist-delivered treatment. Mechanistic evidence implicates reduced dysfunctional beliefs and pre-sleep arousal, while physiological evidence (HPA axis, inflammation) remains preliminary. Sleep restriction is the most potent but most burdensome component, producing transient sleepiness that necessitates screening and safety guidance. Sleep hygiene alone is insufficient.

Conclusions: Self-implementation is feasible for appropriately screened adults and is best supported by a structured diary, a standardized titration algorithm, explicit safety rules, and adherence supports such as implementation intentions. Clear referral criteria are essential. Key research gaps include mediators of change, predictors of self-help response, and systematic reporting of adverse effects.

Keywords: cognitive behavioral therapy for insomnia; stimulus control; sleep restriction therapy; self-help; digital CBT-I; sleep efficiency; mechanisms of change

1. Introduction

Insomnia disorder is characterized by difficulty initiating or maintaining sleep, or early-morning awakening, accompanied by daytime impairment, despite adequate opportunity for sleep. For the chronic form, symptoms occur at least three nights per week for at least three months (American Psychiatric Association [APA], 2013). Insomnia symptoms are common, and a diagnosable insomnia disorder affects roughly 10% of adults (Morin & Benca, 2012; Morin & Jarrin, 2022). It is associated with reduced quality of life and with increased risk of subsequent depression (Baglioni et al., 2011; Hertenstein et al., 2019).

Guidelines from the American College of Physicians, the American Academy of Sleep Medicine, and the European Sleep Research Society all recommend CBT-I as first-line treatment, ahead of pharmacotherapy (Edinger et al., 2021; Qaseem et al., 2016; Riemann et al., 2023). The evidence reviews underpinning these guidelines found consistent benefits for sleep outcomes, with fewer safety concerns than medication (Brasure et al., 2016; Sateia et al., 2017). Delivery of CBT-I is nevertheless constrained by a shortage of trained clinicians, which has driven the development of internet-delivered, book-based, and app-based programs (Espie et al., 2012; Zachariae et al., 2016).

Many people attempt to apply CBT-I principles on their own. This creates two problems. First, popular summaries often omit the logic that makes techniques work, such as why time in bed is restricted. This leads to poor adherence or unsafe application. Second, the self-help literature is frequently cited without regard to its limits. This review therefore pursues three aims: to explain how CBT-I is thought to work, to appraise the evidence for its components and delivery formats, and to provide a safety-conscious framework for self-implementation.

2. Theoretical and Mechanistic Foundations

2.1 The three-factor model

The most widely used framework for CBT-I is the three-factor ("3P") model (Spielman et al., 1987a). It distinguishes predisposing factors (e.g., heightened sleep reactivity to stress; Drake et al., 2011; Kalmbach et al., 2018), precipitating factors (e.g., a stressful life event), and perpetuating factors, which are the behavioral and cognitive responses to poor sleep that maintain it after the precipitant has resolved. Most people who develop acute insomnia recover (Ellis et al., 2012). A subset do not, and the model proposes that their trajectory is driven by maladaptive coping rather than the initial trigger. This is why CBT-I targets perpetuating factors rather than the original cause.

Typical perpetuating behaviors include extending time in bed to "catch up," napping, irregular schedules, and wakeful activity in bed. These responses are intuitively reasonable but counterproductive. They dilute homeostatic sleep pressure, weaken circadian regularity, and increase time spent awake in the sleep environment.

2.2 Sleep regulation and the logic of sleep restriction

The two-process model describes sleep timing and depth as the product of a homeostatic drive that accumulates with wakefulness (Process S) and a circadian signal (Process C) (Borbély, 1982; Borbély et al., 2016). Extending time in bed lowers accumulated sleep pressure at bedtime and increases the opportunity for fragmented sleep. Sleep restriction therapy applies this logic by temporarily limiting time in bed to approximate the person's actual sleep time, which increases sleep pressure and consolidates sleep (Spielman et al., 1987b). Although the homeostatic account is plausible and widely cited, direct mechanistic tests in patients with insomnia are limited, and the evidence for sleep restriction rests primarily on clinical outcomes (Miller et al., 2014).

2.3 Conditioning and arousal

Stimulus control derives from the proposal that, in insomnia, the bed and bedroom become conditioned cues for arousal and frustration rather than sleep (Bootzin, 1972). Neurocognitive and hyperarousal models extend this view, proposing that elevated cognitive and physiological arousal prevents the sleep-onset process (Perlis et al., 1997; Riemann et al., 2010). Pre-sleep cognitive activity, such as worry and rumination, is a prominent feature of insomnia (Nicassio et al., 1985). The attention-intention-effort pathway proposes that effortful attempts to sleep, combined with selective attention to sleep-related threat, further disrupt sleep initiation (Espie et al., 2006).

2.4 Cognitive models

Harvey's (2002) cognitive model proposes that excessive negative cognitive activity, selective attention to threat, distorted perception of sleep and daytime deficits, and safety behaviors form a self-maintaining loop. Dysfunctional beliefs about sleep (e.g., unrealistic expectations of sleep need, catastrophic consequences of poor sleep) are measured with the Dysfunctional Beliefs and Attitudes about Sleep scale (Morin et al., 2007) and are the principal target of cognitive therapy.

2.5 Empirical evidence on mediators of change

A systematic review and meta-analysis of mediators of CBT-I found that changes in dysfunctional beliefs about sleep, pre-sleep arousal, and related cognitive-behavioral variables were the most frequently supported mediators, but it also noted that most studies lacked the temporal design needed to establish mediation (Parsons et al., 2022). Within a randomized comparison of behavior therapy, cognitive therapy, and combined treatment, dysfunctional beliefs changed across treatments, consistent with shared cognitive effects (Eidelman et al., 2016; Harvey et al., 2014). The mediation literature should therefore be regarded as suggestive rather than conclusive.

2.6 Physiological correlates

A meta-analysis of case-control studies found modest evidence of elevated hypothalamic-pituitary-adrenal (HPA) axis activity in chronic insomnia, with heterogeneity across measures and sampling times (Dressle et al., 2022; see also Dressle & Riemann, 2023). Sleep disturbance is also associated with markers of systemic inflammation (Irwin et al., 2016), and in older adults with insomnia, CBT-I has been reported to reduce inflammatory risk markers (Irwin et al., 2014). These findings offer a plausible biological account, but they do not yet establish that CBT-I operates through HPA or inflammatory pathways. They should be framed as hypotheses.

3. Core Components of CBT-I

Standard CBT-I is delivered over about four to eight sessions, with the order of modules varying across protocols (Edinger et al., 2021). Sleep restriction is sometimes introduced early because of its potency, but sequencing is a clinical decision rather than a validated requirement.

4. Evidence for Efficacy

4.1 Therapist-delivered CBT-I

A meta-analysis of randomized trials found that CBT-I reduced sleep onset latency by about 19 minutes and wake after sleep onset by about 26 minutes, with a roughly 10 percentage-point increase in sleep efficiency (Trauer et al., 2015). Another meta-analysis reported large effects on insomnia severity (van Straten et al., 2018). Comparisons with medication indicate that CBT-I provides more durable benefits after treatment ends (Mitchell et al., 2012; Morin et al., 2009). A meta-analysis of long-term outcomes found that effects were largely maintained at follow-up (van der Zweerde et al., 2019).

4.2 Comorbid conditions and mental health

CBT-I improves sleep in people with comorbid psychiatric and medical conditions, with moderate benefits and smaller secondary effects on comorbid symptoms (Wu et al., 2015). Improving sleep is associated with better mental health outcomes in a meta-analysis of randomized trials (Scott et al., 2021). Digital CBT-I reduced depressive symptoms in an insomnia sample (Christensen et al., 2016) and reduced paranoia and hallucinations in university students (Freeman et al., 2017). In people with obstructive sleep apnea and comorbid insomnia, CBT-I improved insomnia and increased adherence to CPAP (Sweetman et al., 2019).

4.3 Self-help and digital delivery

Meta-analyses indicate that self-help CBT-I produces improvements in sleep, but with smaller and more variable effects than therapist-delivered treatment (Ho et al., 2015; van Straten & Cuijpers, 2009). Internet-delivered CBT-I shows moderate to large effects (Zachariae et al., 2016), and a network meta-analysis supports digital CBT-I as an effective modality (Hasan et al., 2022). A large randomized trial of a fully automated program showed improvements in insomnia, wellbeing, and sleep-related quality of life (Espie et al., 2019). Nurse-delivered sleep restriction therapy was superior to sleep hygiene at six months in a primary care trial (Kyle et al., 2023). Taken together, these data support structured self-help but not unstructured self-help based on brief summaries.

4.4 Safety of sleep restriction

Sleep restriction therapy can transiently reduce objective sleep time, increase daytime sleepiness, and impair vigilance during the early weeks (Kyle et al., 2014). In a randomized comparison, sleep restriction did not produce a greater risk of objective sleepiness than full CBT-I (Cheng et al., 2020). These findings are compatible: sleepiness is a recognized early effect of the behavioral components, and it should be anticipated and managed rather than dismissed. Behavioral sleep restriction may also increase risk in bipolar disorder, where sleep loss can precipitate mania, and in seizure disorders (Kaplan & Harvey, 2013; Kyle et al., 2014). Adverse event reporting in this literature remains inconsistent (Maurer et al., 2021).

5. A Framework for Guided Self-Implementation

This framework is derived from the evidence above and from standard protocols (Edinger et al., 2021; Spielman et al., 1987b). It is not a substitute for clinical care.

5.1 Step 0: Screen for suitability and safety

Self-implementation is generally reasonable for adults with chronic insomnia and no serious comorbid conditions. The Insomnia Severity Index provides a validated baseline and severity range (Bastien et al., 2001). Seek professional assessment before starting if any of the following apply:

• Suspected sleep apnea (loud snoring, witnessed breathing pauses, marked daytime sleepiness, or an elevated STOP-Bang score; Chung et al., 2008)

• A history of bipolar disorder, a seizure disorder, or parasomnias

• Significant depression, anxiety, or suicidal thoughts

• Safety-critical daytime work, including driving long distances, that cannot tolerate temporary sleepiness

• Pregnancy or major medical illness, where sleep restriction should be individualized

5.2 Step 1: Keep a sleep diary for 1-2 weeks

Use a standardized format such as the Consensus Sleep Diary (Carney et al., 2012). Record bedtime, estimated time to fall asleep, awakenings, final awakening, out-of-bed time, and sleep quality. Sleep efficiency (SE) is total sleep time divided by time in bed, multiplied by 100. Be consistent about the denominator, because definitions of time in bed vary (Reed & Sacco, 2016).

5.3 Step 2: Set the initial sleep window

Set the window to the mean total sleep time plus about 30 minutes, but not below 5 hours (Spielman et al., 1987b). Fix the wake time first, and calculate bedtime backward.

Worked example. A person averages 5.5 hours of sleep in 8 hours in bed (SE = 69%). The window is 6 hours. With a fixed rising time of 06:30, bedtime is 00:30.

5.4 Step 3: Titrate weekly

Thresholds vary between protocols, so the following is one commonly used scheme (Kyle et al., 2014; Maurer et al., 2021):

5.5 Step 4: Apply stimulus control from the first night

The standard rules are to go to bed only when sleepy, to use the bed only for sleep and intimacy, to get up at the same time every day, to avoid napping, and to leave the bed when unable to sleep (Bootzin, 1972; Morin et al., 1999). The common "about 20 minutes" guideline is a heuristic that should be applied without clock-watching. Do the out-of-bed activity in low light and return only when sleepy.

5.6 Step 5: Address beliefs and pre-sleep arousal

Identify unhelpful beliefs, for example from the Dysfunctional Beliefs and Attitudes about Sleep scale (Morin et al., 2007), and test them against evidence from your own diary. A thought record with a "balanced alternative" column is a practical format. For pre-sleep arousal, schedule a "worry time" earlier in the evening and practice relaxation. Slow, paced breathing has a physiological rationale (Zaccaro et al., 2018), whereas the popular 4-7-8 pattern has no trial support specific to insomnia, so any comfortable slow rhythm is a reasonable substitute. Mindfulness practice has trial support as an adjunct (Ong et al., 2014).

5.7 Step 6: Sleep hygiene as support only

Hygiene advice (caffeine timing, light, noise, temperature) can supplement but not replace the behavioral components (Chung et al., 2018).

5.8 Adherence

Adherence is the main practical challenge. Self-efficacy, which is the belief in one's ability to carry out a behavior, is central to behavior change (Bandura, 1997). Implementation intentions ("If it is 06:30, then I get out of bed and open the curtains") improve follow-through on difficult behaviors (Gollwitzer, 1999). Expect early sleepiness. Avoid driving when drowsy, and relax the window if you cannot function safely.

5.9 Troubleshooting and referral

Seek professional care if there is no improvement after about 4-6 weeks of faithful practice, if mood worsens, if you have safety concerns, or if sleep apnea or another disorder is suspected. A clinician can personalize the program, address comorbidities, and consider combined approaches.

6. Limitations and Future Directions

This is a narrative rather than a systematic review, and its conclusions are limited accordingly. The self-help evidence comes largely from structured programs, so it may not generalize to unstructured use of the principles described here. The framework is not itself empirically validated as a self-help protocol and should be tested. Priorities for future research include rigorous mediation designs, identification of who responds to self-help, reporting of adverse events, and the physiological mechanisms of change.

7. Conclusion

CBT-I works by dismantling the behaviors and cognitions that perpetuate insomnia rather than by treating its original cause. The evidence supports its efficacy and durability, and structured self-help and digital formats extend access, albeit with smaller and more variable benefits. Safe self-implementation requires screening, a diary-driven titration scheme, explicit safety rules, adherence supports, and clear referral criteria.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.

Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135(1-3), 10-19.

Bandura, A. (1997). Self-efficacy: The exercise of control. W. H. Freeman.

Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297-307.

Bootzin, R. R. (1972). Stimulus control treatment for insomnia. Proceedings of the 80th Annual Convention of the American Psychological Association, 7, 395-396.

Borbély, A. A. (1982). A two process model of sleep regulation. Human Neurobiology, 1(3), 195-204.

Borbély, A. A., Daan, S., Wirz-Justice, A., & Deboer, T. (2016). The two-process model of sleep regulation: A reappraisal. Journal of Sleep Research, 25(2), 131-143.

Brasure, M., Fuchs, E., MacDonald, R., Nelson, V. A., Koffel, E., Olson, C. M., Khawaja, I. S., Diem, S., Carlyle, M., Wilt, T. J., Ouellette, J., Butler, M., & Kane, R. L. (2016). Psychological and behavioral interventions for managing insomnia disorder: An evidence report for a clinical practice guideline by the American College of Physicians. Annals of Internal Medicine, 165(2), 113-124.

Carney, C. E., Buysse, D. J., Ancoli-Israel, S., Edinger, J. D., Krystal, A. D., Lichstein, K. L., & Morin, C. M. (2012). The Consensus Sleep Diary: Standardizing prospective sleep self-monitoring. Sleep, 35(2), 287-302.

Cheng, P., Kalmbach, D. A., Fellman-Couture, C., Arnedt, J. T., Cuamatzi-Castelan, A., & Drake, C. L. (2020). Risk of excessive sleepiness in sleep restriction therapy and cognitive behavioral therapy for insomnia: A randomized controlled trial. Journal of Clinical Sleep Medicine, 16(2), 193-198.

Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P., Glozier, N., O'Dea, B., Hickie, I. B., & Mackinnon, A. J. (2016). Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): A randomised controlled trial. The Lancet Psychiatry, 3(4), 333-341.

Chung, F., Yegneswaran, B., Liao, P., Chung, S. A., Vairavanathan, S., Islam, S., Khajehdehi, A., & Shapiro, C. M. (2008). STOP questionnaire: A tool to screen patients for obstructive sleep apnea. Anesthesiology, 108(5), 812-821.

Chung, K.-F., Lee, C.-T., Yeung, W.-F., Chan, M.-S., Chung, E. W.-Y., & Lin, W.-L. (2018). Sleep hygiene education as a treatment of insomnia: A systematic review and meta-analysis. Family Practice, 35(4), 365-375.

Drake, C. L., Friedman, N. P., Wright, K. P., Jr., & Roth, T. (2011). Sleep reactivity and insomnia: Genetic and environmental influences. Sleep, 34(9), 1179-1188.

Dressle, R. J., Feige, B., Spiegelhalder, K., Schmucker, C., Benz, F., Mey, N. C., & Riemann, D. (2022). HPA axis activity in patients with chronic insomnia: A systematic review and meta-analysis of case-control studies. Sleep Medicine Reviews, 62, Article 101588.

Dressle, R. J., & Riemann, D. (2023). Hyperarousal in insomnia disorder: Current evidence and potential mechanisms. Journal of Sleep Research, 32(6), Article e13928.

Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., & Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255-262.

Eidelman, P., Talbot, L., Ivers, H., Bélanger, L., Morin, C. M., & Harvey, A. G. (2016). Change in dysfunctional beliefs about sleep in behavior therapy, cognitive therapy, and cognitive-behavioral therapy for insomnia. Behavior Therapy, 47(1), 102-115.

Ellis, J. G., Perlis, M. L., Neale, L. F., Espie, C. A., & Bastien, C. H. (2012). The natural history of insomnia: Focus on prevalence and incidence of acute insomnia. Journal of Psychiatric Research, 46(10), 1278-1285.

Espie, C. A., Broomfield, N. M., MacMahon, K. M. A., Macphee, L. M., & Taylor, L. M. (2006). The attention-intention-effort pathway in the development of psychophysiologic insomnia: A theoretical review. Sleep Medicine Reviews, 10(4), 215-245.

Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., Cape, J., Ong, J. C., Sheaves, B., Foster, R., Freeman, D., Costa-Font, J., Marsden, A., & Luik, A. I. (2019). Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: A randomized clinical trial. JAMA Psychiatry, 76(1), 21-30.

Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. L. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.

Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L.-M., Nickless, A., Harrison, P. J., Emsley, R., Luik, A. I., Foster, R. G., Wadekar, V., Hinds, C., Gumley, A., Jones, R., Lightman, S., Jones, S., Bentall, R., Kinderman, P., Rowse, G., Brugha, T., ... Espie, C. A. (2017). The effects of improving sleep on mental health (OASIS): A randomised controlled trial with mediation analysis. The Lancet Psychiatry, 4(10), 749-758.

Gollwitzer, P. M. (1999). Implementation intentions: Strong effects of simple plans. American Psychologist, 54(7), 493-503.

Harvey, A. G. (2002). A cognitive model of insomnia. Behaviour Research and Therapy, 40(8), 869-893.

Harvey, A. G., Bélanger, L., Talbot, L., Eidelman, P., Beaulieu-Bonneau, S., Fortier-Brochu, É., Ivers, H., Lamy, M., Mérette, C., Soehner, A., & Morin, C. M. (2014). Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 82(4), 670-683.

Hasan, F., Tu, Y.-K., Yang, C.-M., James Gordon, C., Wu, D., Lee, H.-C., Yuliana, L. T., Herawati, L., Chen, T.-J., & Chiu, H.-Y. (2022). Comparative efficacy of digital cognitive behavioral therapy for insomnia: A systematic review and network meta-analysis. Sleep Medicine Reviews, 61, Article 101567.

Hertenstein, E., Feige, B., Gmeiner, T., Kienzler, C., Spiegelhalder, K., Johann, A., Jansson-Fröjmark, M., Palagini, L., Rücker, G., Riemann, D., & Baglioni, C. (2019). Insomnia as a predictor of mental disorders: A systematic review and meta-analysis. Sleep Medicine Reviews, 43, 96-105.

Ho, F. Y.-Y., Chung, K.-F., Yeung, W.-F., Ng, T. H., Kwan, K.-S., Yung, K.-P., & Cheng, S. K. (2015). Self-help cognitive-behavioral therapy for insomnia: A meta-analysis of randomized controlled trials. Sleep Medicine Reviews, 19, 17-28.

Irwin, M. R., Olmstead, R., Carrillo, C., Sadeghi, N., Breen, E. C., Witarama, T., Yokomizo, M., Lavretsky, H., Carroll, J. E., Motivala, S. J., Bootzin, R., & Nicassio, P. (2014). Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: A randomized controlled comparative efficacy trial. Sleep, 37(9), 1543-1552.

Irwin, M. R., Olmstead, R., & Carroll, J. E. (2016). Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biological Psychiatry, 80(1), 40-52.

Kalmbach, D. A., Anderson, J. R., & Drake, C. L. (2018). The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders. Journal of Sleep Research, 27(6), Article e12710.

Kaplan, K. A., & Harvey, A. G. (2013). Behavioral treatment of insomnia in bipolar disorder. American Journal of Psychiatry, 170(7), 716-720.

Kyle, S. D., Aquino, M. R. J., Miller, C. B., Henry, A. L., Crawford, M. R., Espie, C. A., & Spielman, A. J. (2014). Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: Implications for the clinical management of insomnia disorder. Sleep, 37(2), 229-237.

Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yu, L.-M., Climie, R., Bouchet, P. L., Bower, P., Ellis, J. G., Forbes, A., Hay-Smith, E. J. C., Heneghan, C., Jasper, J., McCulloch, M., Miller, C. B., Pitson, D., Whitehouse, A., & Maurer, L. F. (2023). Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): A pragmatic, superiority, open-label, randomised controlled trial. The Lancet, 402(10406), 975-987.

Maurer, L. F., Schneider, J., Miller, C. B., Espie, C. A., & Kyle, S. D. (2021). The clinical effects of sleep restriction therapy for insomnia: A meta-analysis of randomised controlled trials. Sleep Medicine Reviews, 58, Article 101493.

Miller, C. B., Espie, C. A., Epstein, D. R., Friedman, L., Morin, C. M., Pigeon, W. R., Spielman, A. J., & Kyle, S. D. (2014). The evidence base of sleep restriction therapy for treating insomnia disorder. Sleep Medicine Reviews, 18(5), 415-424.

Mitchell, M. D., Gehrman, P., Perlis, M., & Umscheid, C. A. (2012). Comparative effectiveness of cognitive behavioral therapy for insomnia: A systematic review. BMC Family Practice, 13, Article 40.

Morin, C. M., & Benca, R. (2012). Chronic insomnia. The Lancet, 379(9821), 1129-1141.

Morin, C. M., Hauri, P. J., Espie, C. A., Spielman, A. J., Buysse, D. J., & Bootzin, R. R. (1999). Nonpharmacologic treatment of chronic insomnia. Sleep, 22(8), 1134-1156.

Morin, C. M., & Jarrin, D. C. (2022). Epidemiology of insomnia: Prevalence, course, risk factors, and public health burden. Sleep Medicine Clinics, 17(2), 173-191.

Morin, C. M., Vallières, A., Guay, B., Ivers, H., Savard, J., Mérette, C., Bastien, C., & Baillargeon, L. (2009). Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. JAMA, 301(19), 2005-2015.

Morin, C. M., Vallières, A., & Ivers, H. (2007). Dysfunctional beliefs and attitudes about sleep (DBAS): Validation of a brief version (DBAS-16). Sleep, 30(11), 1547-1554.

Nicassio, P. M., Mendlowitz, D. R., Fussell, J. J., & Petras, L. (1985). The phenomenology of the pre-sleep state: The development of the pre-sleep arousal scale. Behaviour Research and Therapy, 23(3), 263-271.

Ong, J. C., Manber, R., Segal, Z., Xia, Y., Shapiro, S., & Wyatt, J. K. (2014). A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep, 37(9), 1553-1563.

Parsons, C. E., Zachariae, R., Landberger, C., & Young, K. S. (2022). How does cognitive behavioural therapy for insomnia work? A systematic review and meta-analysis of mediators of change. Clinical Psychology Review, 86, Article 102027.

Perlis, M. L., Giles, D. E., Mendelson, W. B., Bootzin, R. R., & Wyatt, J. K. (1997). Psychophysiological insomnia: The behavioural model and a neurocognitive perspective. Journal of Sleep Research, 6(3), 179-188.

Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.

Reed, D. L., & Sacco, W. P. (2016). Measuring sleep efficiency: What should the denominator be? Journal of Clinical Sleep Medicine, 12(2), 263-266.

Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., Bastien, C., Berzina, N., Bjorvatn, B., Dikeos, D., Dolenc Groselj, L., Ellis, J. G., Garcia-Borreguero, D., Geoffroy, P. A., Gjerstad, M., Gonçalves, M., Hertenstein, E., Hoedlmoser, K., Hion, T., ... Spiegelhalder, K. (2023). The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research, 32(6), Article e14035.

Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010). The hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Medicine Reviews, 14(1), 19-31.

Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(2), 307-349.

Scott, A. J., Webb, T. L., Martyn-St James, M., Rowse, G., & Weich, S. (2021). Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials. Sleep Medicine Reviews, 60, Article 101556.

Spielman, A. J., Caruso, L. S., & Glovinsky, P. B. (1987a). A behavioral perspective on insomnia treatment. Psychiatric Clinics of North America, 10(4), 541-553.

Spielman, A. J., Saskin, P., & Thorpy, M. J. (1987b). Treatment of chronic insomnia by restriction of time in bed. Sleep, 10(1), 45-56.

Stepanski, E. J., & Wyatt, J. K. (2003). Use of sleep hygiene in the treatment of insomnia. Sleep Medicine Reviews, 7(3), 215-225.

Sweetman, A., Lack, L., Catcheside, P. G., Antic, N. A., Chai-Coetzer, C. L., Smith, S. S., Douglas, J. A., & McEvoy, R. D. (2019). Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: A randomized clinical trial. Sleep, 42(12), Article zsz178.

Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. W., & Cunnington, D. (2015). Cognitive behavioral therapy for chronic insomnia: A systematic review and meta-analysis. Annals of Internal Medicine, 163(3), 191-204.

van der Zweerde, T., Bisdounis, L., Kyle, S. D., Lancee, J., & van Straten, A. (2019). Cognitive behavioral therapy for insomnia: A meta-analysis of long-term effects in controlled studies. Sleep Medicine Reviews, 48, Article 101208.

van Straten, A., & Cuijpers, P. (2009). Self-help therapy for insomnia: A meta-analysis. Sleep Medicine Reviews, 13(1), 61-71.

van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J. (2018). Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Medicine Reviews, 38, 3-16.

Wu, J. Q., Appleman, E. R., Salazar, R. D., & Ong, J. C. (2015). Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: A meta-analysis. JAMA Internal Medicine, 175(9), 1461-1472.

Zaccaro, A., Piarulli, A., Laurino, M., Garbella, E., Menicucci, D., Neri, B., & Gemignani, A. (2018). How breath-control can change your life: A systematic review on psycho-physiological correlates of slow breathing. Frontiers in Human Neuroscience, 12, Article 353.

Zachariae, R., Lyby, M. S., Ritterband, L. M., & O'Toole, M. S. (2016). Efficacy of internet-delivered cognitive-behavioral therapy for insomnia: A systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews, 30, 1-10.